ASMB financials
Assembly Biosciences (ASMB) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ASMB income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $72.30M | $72.17M | -$12.12M | -$6.12M | -0.55 |
| 2024 | $28.52M | -$27.41M | -$45.42M | -$40.18M | -6.69 |
| 2023 | $7.16M | -$41.74M | -$64.65M | -$61.23M | -13.38 |
| 2022 | $0.00 | -$69.08M | -$94.11M | -$93.09M | -22.82 |
| 2021 | $6.25M | $6.25M | -$132.69M | -$129.85M | -36.00 |
| 2020 | $79.11M | -$22.23M | -$64.78M | -$62.15M | -15.00 |
- ASMB revenue was $72.30M in fiscal 2025, net income -$6.12M.
Updated 2026-11-06 11:42 UTC